Callan Family Office’s Corpay CPAY Stock Holding History

Callan Family Office’s Portfolio CPAY Stock Details CPAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$735K	Buy	2,527 +116	+5%	+$37.2K	0.02%	640
2025 Q4	$726K	Buy	2,411 +1,532	+174%	+$445K	0.02%	651
2025 Q3	$253K	Buy	879 +258	+42%	+$82.2K	0.01%	755
2025 Q2	$206K	Buy	+621	New	+$203K	0.01%	886

Other funds holding CPAY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Callan Family Office's CPAY Position: Q1 2026 in Review

Callan Family Office increased its Corpay (CPAY) stake by 4.8% in Q1 2026, buying an estimated $37.2K and bringing the position to 2,527 shares worth $735K. The position accounts for 0.02% of the portfolio, ranked #640.

Callan Family Office first reported a position in CPAY in Q2 2025 and has held it in 4 quarters since. 680 funds tracked by Wall St. Rank hold CPAY as of Q1 2026.

Callan Family Office held 2,527 shares of Corpay worth $735K as of Q1 2026.
Callan Family Office bought 116 Corpay shares in Q1 2026, an estimated $37.2K.
Corpay made up 0.02% of Callan Family Office's portfolio in Q1 2026, its #640 holding.
Callan Family Office first reported a position in Corpay in Q2 2025 and has held it in 4 quarters since.
680 funds tracked by Wall St. Rank held Corpay as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.